Skip to Main Content

Knowledge Center

Underwriting and Claims

Myocardial Infarction Claims: The ups and downs of troponin testing

The advent of ultra-sensitive troponin testing has led to changes in the way the test is applied and has led to the discovery of many “troponin positive” illnesses that are not due to coronary artery disease.

This conundrum has prompted the medical profession to adopt important changes in the clinical definition of MI and means that the insurance industry currently has many in-force critical illness (CI) products that use an MI definition that differs from current clinical practice.

In this session, Dr. Nick Boon, RGA’s Consulting Medical Officer, U.K., and clinical cardiologist, discusses how MI is currently defined and present best practices to adjudicate borderline MI CI claims.


The Presenters

  • Dr. Nick Boon
    Consulting Medical Officer
  • Dr. John J. Lefebre

    Vice President,
    Senior Global Technical Medical Director
    Global Medical

  • Dr. Sheetal Salgaonkar
    Vice President and Medical Director
    Global Medical
    RGA India
    Send email >
  • Acute Respiratory Distress Syndrome
  • ARDS
  • covid claims
  • covid pandemic
  • covid rehab
  • MERS
  • PICS
  • SARS
  • SARS-CoV-2
  • Severe Acute Respiratory Syndrome